Personal Health: Cold Hands May Signal Raynaud ’ s Phenomenon
The condition, affecting up to 5 percent of the population, is uncomfortable but not necessarily dangerous. (Source: NYT Health)
Source: NYT Health - December 5, 2016 Category: Consumer Health News Authors: JANE E. BRODY Tags: Skin Anxiety and Stress Scleroderma Seasons and Months Source Type: news
Top-performing Mass. biotech Corbus extends study of promising drug
Norwood-based Corbus Pharmaceuticals, the top-performing biotech stock in the state so far in 2016, said Tuesday that it will extend a Phase 2 study of its only drug in development.
Corbus (Nasdaq: CRBP) said that the FDA had approved a one-year, open-label extension study of the trial of anti-inflammatory drug Resunab to treat skin-predominant dermatomyositis. In April, the regulator approved a one-year extension study of Resunab for patients with systemic sclerosis. The com pany said in a statement… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 29, 2016 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news
Lactose Malabsorption in Systemic Sclerosis Lactose Malabsorption in Systemic Sclerosis
This study investigated the relationship between dietary lactose intake and gastrointestinal dysfunction.Alimentary Pharmacology & Therapeutics (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 15, 2016 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news
Corbus drug succeeds in mid-stage scleroderma study, shares surge
(Reuters) - Corbus Pharmaceuticals Holdings Inc said its only drug outperformed a placebo in a mid-stage study involving patients with a form of systemic sclerosis, an incurable autoimmune condition caused by abnormal growth of connective tissue. (Source: Reuters: Health)
Source: Reuters: Health - November 14, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
Dermatology: five pictorial cases and outcomes
Five illustrated cases of skin conditions, including pityriasis/tinea amiantacea, morphea (localised scleroderma), nicorandil-induced ulceration and two cases showing the effectiveness of topical chemotherapy agents in skin dysplasia. (Source: GP Online Education)
Source: GP Online Education - November 8, 2016 Category: Primary Care Tags: 15.10 Skin Problems Source Type: news
Risk Factors for PAH Development in Systemic Sclerosis Risk Factors for PAH Development in Systemic Sclerosis
Which factors may contribute to the development of pulmonary arterial hypertension among patients with systemic sclerosis?BMC Pulmonary Medicine (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 7, 2016 Category: Surgery Tags: Pulmonary Medicine Journal Article Source Type: news
Rituximab Effective Long-Term for Systemic Sclerosis (CME/CE)
(MedPage Today) -- The B-cell depletion therapy may fill a need for safe agents that stabilize lung function (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 5, 2016 Category: Rheumatology Source Type: news
Study identifies method for slowing skin fibrosis in scleroderma
Ryan MaassNEW YORK, Oct. 31 (UPI) -- Researchers at the Hospital for Special Surgery in New York City have uncovered a potential method for slowing skin fibrosis for patients with scleroderma. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 31, 2016 Category: Consumer Health News Source Type: news
New study suggests way to slow skin fibrosis in scleroderma
A possible mechanism behind the fibrosis that occurs in scleroderma has now been identified, a mechanism, researchers say, that may one day lead to a treatment for the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 31, 2016 Category: Science Source Type: news
New study suggests way to slow skin fibrosis in scleroderma
(Hospital for Special Surgery) New and ongoing research at Hospital for Special Surgery in New York City has identified a possible mechanism behind the fibrosis that occurs in scleroderma -- a mechanism that may one day lead to a treatment for the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 31, 2016 Category: Global & Universal Source Type: news
Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease
(Source: Boehringer Ingelheim Press Releases)
Source: Boehringer Ingelheim Press Releases - September 8, 2016 Category: Research Source Type: news
Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - September 7, 2016 Category: Research Source Type: news
Nailfold Capillaroscopy Excludes Scleroderma in Raynaud ’s (CME/CE)
(MedPage Today) -- Test had impressive 90% negative predictive value for SSc (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 26, 2016 Category: Dermatology Source Type: news
Should Women Have Breast Implants Removed?
It was a story with a bit of irony, as well as ominous health warnings.
Crystal Hefner, the 30-year-old wife of Playboy magazine mogul Hugh Hefner, announced in a story in People magazine last month that she'd had her breast implants removed because they were making her sick.
Hefner posted a photo of her post-surgery self on Instagram with the caption, "Using 2016 to reclaim my health and embrace and love myself for the real me."
The former model, now a DJ, was diagnosed a few months back with Lyme disease. Her symptoms included intolerance to foods and beverages as well as back, neck, and shoulder pain.
Hefner also su...
Source: Healthy Living - The Huffington Post - August 2, 2016 Category: Consumer Health News Source Type: news
